BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF SOFOSBUVIR FROM HUMAN PLASMA
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2017, Vol 9, Issue 3
Abstract
Objective: This study points to build up and validate a simple methodology to quantify the most used drug sofosbuvir for the treatment of hepatitis C virus (HCV) infection, in human plasma by using atazanavir as an Internal Standard (IS) for preclinical studies and validate as per USFDA guidelines.Methods: Sofosbuvir was isolated from plasma samples by liquid-liquid extraction method using acetonitrile; good chromatographic separation was achieved on Kromasil Column (250 mm ×4.6 mm, 5 µm). The mobile phase consisted of 0.1 % orthophosphoric acid (OPA) buffer pH 2 and acetonitrile in the ratio of (68:32, v/v), respectively. The analysis time was 7 min at a flow rate 1 ml/min. The photodiode array detector (PDA) detection was carried out at 228 nm. The suggested method was validated by performing linearity, system suitability, specificity and sensitivity, accuracy and precision, recovery, ruggedness, stability studies. The method was validated as per USFDA guidelines.Results: The developed method resulted in retention times of sofosbuvir and IS were found out to be 4.7 and 4.2 min respectively. The calibration curves are linear (r2 = 0.999) over the concentration range of 0.050-2.0 µg/ml of plasma analytes concentration. LOQ value was found to be 0.050 µg/ml with precision and accuracy. Within-batch % mean accuracy of the method ranged between 96.00% and 109.09%, and within-batch and total precision, expressed as the coefficient of variation, was 1.40–10.33%. Overall percentage mean recovery of sofosbuvir from spiked plasma was 84.14%. All the validated parameters were found to be within the limit.Conclusion: A simple, accurate, precise, linear, rugged and rapid RP-HPLC method was developed for quantitative estimation of sofosbuvir in human plasma and should be suitable for conducting pharmacokinetics studies and therapeutic drug monitoring.
Authors and Affiliations
S. Madhavi, A. Prameela Rani
Keywords
Related Articles
- EP ID EP575718
- DOI 10.22159/ijpps.2017v9i3.16185
- Views 77
- Downloads 0
MOLECULAR DOCKING, DESIGN, SYNTHESIS, IN VITRO ANTIOXIDANT AND ANTI-INFLAMMATORY EVALUATIONS OF NEW ISOQUINOLINE DERIVATIVES
Objectives: To design and synthesis N-substituted (E)-4-arylidene-isoquinoline-1,3-dione derivatives as anti-inflammatory and antioxidant drug moieties using molecular docking as a tool.Methods: The structure of compound...
TRADITIONAL HEALING WITH ANIMALS (ZOOTHERAPY) BY THE MAJOR ETHNIC GROUP OF KARBI ANGLONG DISTRICT OF ASSAM, INDIA
Objective: To survey and document the traditional knowledge related to medicinal uses of animals among the ethnic groups in Karbi Anglong district of Assam.Methods: A long term field survey was conducted from July 2008 t...
NEUROPROTECTIVE POTENTIAL AND EFFICACY OF NEURODEGENERATIVE DISORDERS OF FRUIT EXTRACT OF AEGLE MARMELOS
Objective: To evaluate the neuroprotective and neurodegenerative disorder of Aegle marmelos.Methods: The present study was carried out to evaluate the Alzhiemer and Parkinsonism disorders by Actophotometer test. Water ma...
ANTI-OXIDANT AND ANTI-MICROBIAL ACTIVITIES OF SYNTHETIC 3-FORMYL, 7-FLAVONOL INTERMEDIATES OBTAINED BY MICROWAVE ASSISTED TECHNIQUE
Objective: The synthesized compounds of 3-formyl, 7-flavonols*, after characterization, aimed to be tested for their anti-oxidant and anti-microbial activities.Methods: i) anti-oxidant activities by hydrogen peroxide-nit...
DESIGN OF A FUZZY MODEL FOR THALASSEMIA DISEASE DIAGNOSIS: USING MAMDANI TYPE FUZZY INFERENCE SYSTEM (FIS)
Objective: Diagnosis process of Thalassemia requires several types of medical test, and results of this test together identify the stage of Thalassemia. The objective of this study is to design a Fuzzy Inference System t...